Ullamari Pesonen

Turku, Finland

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 21 publications

Student Perceptions of a Virtual Reality Animation for Teaching Absorption and Bioavailability in Pharmacology: A Mixed Methods Evaluation.

Student Perceptions of a Virtual Reality Animation for Teaching Absorption and Bioavailability in Pharmacology: A Mixed Methods Evaluation.

Journal: Pharmacology research & perspectives
Published: March 23, 2025

Epitope-specific antibody fragments block aggregation of AGelD187N, an aberrant peptide in gelsolin amyloidosis.

Epitope-specific antibody fragments block aggregation of AGelD187N, an aberrant peptide in gelsolin amyloidosis.

Journal: The Journal of biological chemistry
Published: April 26, 2024

5-HT6 receptor antagonists. Design, synthesis, and structure-activity relationship of substituted 2-(1-methyl-4-piperazinyl)pyridines.

5-HT6 receptor antagonists. Design, synthesis, and structure-activity relationship of substituted 2-(1-methyl-4-piperazinyl)pyridines.

Journal: Bioorganic & medicinal chemistry letters
Published: August 30, 2023

Development of an in vitro aggregation assay for long synthetic polypeptide, amyloidogenic gelsolin fragment AGelD187N 173-242.

Development of an in vitro aggregation assay for long synthetic polypeptide, amyloidogenic gelsolin fragment AGelD187N 173-242.

Journal: PloS one
Published: April 11, 2023

Feasibility and patient acceptability of a commercially available wearable and a smart phone application in identification of motor states in parkinson's disease.

Feasibility and patient acceptability of a commercially available wearable and a smart phone application in identification of motor states in parkinson's disease.

Journal: PLOS digital health
Published: May 24, 2022

Tasipimidine-the pharmacological profile of a novel orally active selective α2A-adrenoceptor agonist.

Tasipimidine-the pharmacological profile of a novel orally active selective α2A-adrenoceptor agonist.

Journal: European journal of pharmacology
Published: March 09, 2022

Effects of fadolmidine, an α2 -adrenoceptor agonist, as an adjuvant to spinal bupivacaine on antinociception and motor function in rats and dogs.

Effects of fadolmidine, an α2 -adrenoceptor agonist, as an adjuvant to spinal bupivacaine on antinociception and motor function in rats and dogs.

Journal: Pharmacology research & perspectives
Published: June 03, 2021

Fadolmidine - Favourable adverse effects profile for spinal analgesia suggested by in vitro and in vivo models.

Fadolmidine - Favourable adverse effects profile for spinal analgesia suggested by in vitro and in vivo models.

Journal: European journal of pharmacology
Published: January 10, 2020

Neurophysiology and genetics of burning mouth syndrome.

Neurophysiology and genetics of burning mouth syndrome.

Journal: European journal of pain (London, England)
Published: October 16, 2018

Neuropeptide Y Overexpressing Female and Male Mice Show Divergent Metabolic but Not Gut Microbial Responses to Prenatal Metformin Exposure.

Neuropeptide Y Overexpressing Female and Male Mice Show Divergent Metabolic but Not Gut Microbial Responses to Prenatal Metformin Exposure.

Journal: PloS one
Published: April 15, 2016

1-Sulfonyl-6-Piperazinyl-7-Azaindoles as potent and pseudo-selective 5-HT6 receptor antagonists.

1-Sulfonyl-6-Piperazinyl-7-Azaindoles as potent and pseudo-selective 5-HT6 receptor antagonists.

Journal: Bioorganic & medicinal chemistry letters
Published: February 19, 2016

Novel delivery systems for improving the clinical use of peptides.

Novel delivery systems for improving the clinical use of peptides.

Journal: Pharmacological reviews
Published: May 30, 2015
Showing 1-12 of 21

Last Updated: 09/26/2026